

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glucocorticoid metabolic process (GO:0008211) | 9.76475527 |
| 2 | C21-steroid hormone biosynthetic process (GO:0006700) | 7.75091966 |
| 3 | androgen biosynthetic process (GO:0006702) | 7.30240454 |
| 4 | keratan sulfate catabolic process (GO:0042340) | 6.47985290 |
| 5 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 6.23656654 |
| 6 | cellular response to antibiotic (GO:0071236) | 5.84050017 |
| 7 | cellular response to epinephrine stimulus (GO:0071872) | 5.79320482 |
| 8 | C21-steroid hormone metabolic process (GO:0008207) | 5.57189443 |
| 9 | response to follicle-stimulating hormone (GO:0032354) | 5.47463343 |
| 10 | cellular response to gonadotropin stimulus (GO:0071371) | 5.25913560 |
| 11 | progesterone metabolic process (GO:0042448) | 5.23821971 |
| 12 | extracellular matrix assembly (GO:0085029) | 5.17059987 |
| 13 | response to epinephrine (GO:0071871) | 5.02965569 |
| 14 | low-density lipoprotein particle clearance (GO:0034383) | 4.99720496 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.85913910 |
| 16 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.85913910 |
| 17 | regulation of apoptotic cell clearance (GO:2000425) | 4.78151688 |
| 18 | negative regulation of Rho protein signal transduction (GO:0035024) | 4.60400548 |
| 19 | skeletal muscle adaptation (GO:0043501) | 4.59418475 |
| 20 | surfactant homeostasis (GO:0043129) | 4.58683696 |
| 21 | fusion of sperm to egg plasma membrane (GO:0007342) | 4.46194672 |
| 22 | negative regulation of stress fiber assembly (GO:0051497) | 4.43816256 |
| 23 | blood vessel maturation (GO:0001955) | 4.40261144 |
| 24 | estrogen biosynthetic process (GO:0006703) | 4.38254940 |
| 25 | * regulation of complement activation (GO:0030449) | 4.33565046 |
| 26 | cellular response to toxic substance (GO:0097237) | 4.27527016 |
| 27 | response to insecticide (GO:0017085) | 4.26513412 |
| 28 | protein heterotrimerization (GO:0070208) | 4.20942904 |
| 29 | hormone biosynthetic process (GO:0042446) | 4.18308719 |
| 30 | * regulation of protein activation cascade (GO:2000257) | 4.13935636 |
| 31 | Leydig cell differentiation (GO:0033327) | 4.10127840 |
| 32 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.08628066 |
| 33 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.00644324 |
| 34 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.91366818 |
| 35 | androgen metabolic process (GO:0008209) | 3.91028595 |
| 36 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.89023890 |
| 37 | positive regulation of hormone biosynthetic process (GO:0046886) | 3.88298776 |
| 38 | response to gonadotropin (GO:0034698) | 3.86884158 |
| 39 | plasma membrane fusion (GO:0045026) | 3.77790051 |
| 40 | cardiac myofibril assembly (GO:0055003) | 3.74971639 |
| 41 | cellular response to cadmium ion (GO:0071276) | 3.72426778 |
| 42 | myelination in peripheral nervous system (GO:0022011) | 3.70356866 |
| 43 | peripheral nervous system axon ensheathment (GO:0032292) | 3.70356866 |
| 44 | regulation of cardioblast differentiation (GO:0051890) | 3.69727632 |
| 45 | epithelial cell-cell adhesion (GO:0090136) | 3.65438793 |
| 46 | response to methylmercury (GO:0051597) | 3.62244597 |
| 47 | regulation of endothelial cell differentiation (GO:0045601) | 3.56210816 |
| 48 | * complement activation, alternative pathway (GO:0006957) | 3.52870105 |
| 49 | benzene-containing compound metabolic process (GO:0042537) | 3.51094373 |
| 50 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.50319813 |
| 51 | chemical homeostasis within a tissue (GO:0048875) | 3.50047140 |
| 52 | positive regulation of p38MAPK cascade (GO:1900745) | 3.49494303 |
| 53 | glomerular filtration (GO:0003094) | 3.46367883 |
| 54 | response to water (GO:0009415) | 3.45670616 |
| 55 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.44102126 |
| 56 | cellular response to nitric oxide (GO:0071732) | 3.42691029 |
| 57 | endothelial cell morphogenesis (GO:0001886) | 3.41458970 |
| 58 | * complement activation, classical pathway (GO:0006958) | 3.40115844 |
| 59 | response to corticosterone (GO:0051412) | 3.39177513 |
| 60 | fatty acid transmembrane transport (GO:1902001) | 3.38786871 |
| 61 | renal filtration (GO:0097205) | 3.38284879 |
| 62 | myoblast migration (GO:0051451) | 3.33594559 |
| 63 | cardiac muscle hypertrophy (GO:0003300) | 3.31699296 |
| 64 | ketone biosynthetic process (GO:0042181) | 3.30360447 |
| 65 | valine metabolic process (GO:0006573) | 3.29981497 |
| 66 | extracellular fibril organization (GO:0043206) | 3.24641830 |
| 67 | negative regulation of protein activation cascade (GO:2000258) | 3.23281384 |
| 68 | opsonization (GO:0008228) | 3.21479504 |
| 69 | regulation of p38MAPK cascade (GO:1900744) | 3.20342593 |
| 70 | myofibril assembly (GO:0030239) | 3.18803182 |
| 71 | hormone catabolic process (GO:0042447) | 3.18703819 |
| 72 | mating behavior (GO:0007617) | 3.18350972 |
| 73 | apoptotic cell clearance (GO:0043277) | 3.17903860 |
| 74 | * complement activation (GO:0006956) | 3.17867957 |
| 75 | striated muscle hypertrophy (GO:0014897) | 3.16282894 |
| 76 | negative regulation of actin filament bundle assembly (GO:0032232) | 3.15896163 |
| 77 | brown fat cell differentiation (GO:0050873) | 3.15558375 |
| 78 | negative regulation of protein autophosphorylation (GO:0031953) | 3.13227202 |
| 79 | cellular response to catecholamine stimulus (GO:0071870) | 3.12924155 |
| 80 | cellular response to monoamine stimulus (GO:0071868) | 3.12924155 |
| 81 | cornea development in camera-type eye (GO:0061303) | 3.11255089 |
| 82 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.08903452 |
| 83 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.07373687 |
| 84 | ethanol oxidation (GO:0006069) | 3.05242218 |
| 85 | positive regulation of hormone metabolic process (GO:0032352) | 3.05239425 |
| 86 | regulation of steroid hormone biosynthetic process (GO:0090030) | 3.04982193 |
| 87 | positive regulation of digestive system process (GO:0060456) | 3.04561152 |
| 88 | intracellular lipid transport (GO:0032365) | 3.03352181 |
| 89 | triglyceride catabolic process (GO:0019433) | 3.02456907 |
| 90 | ovulation (GO:0030728) | 3.01218795 |
| 91 | collagen fibril organization (GO:0030199) | 2.97884784 |
| 92 | lymphangiogenesis (GO:0001946) | 2.96677542 |
| 93 | regulation of sequestering of triglyceride (GO:0010889) | 2.96373131 |
| 94 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.94867991 |
| 95 | morphogenesis of an endothelium (GO:0003159) | 2.93515331 |
| 96 | endothelial tube morphogenesis (GO:0061154) | 2.93515331 |
| 97 | muscle hypertrophy (GO:0014896) | 2.93131671 |
| 98 | response to mercury ion (GO:0046689) | 2.92113227 |
| 99 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.91751631 |
| 100 | adrenal gland development (GO:0030325) | 2.91091290 |
| 101 | response to monoamine (GO:0071867) | 2.90545419 |
| 102 | response to catecholamine (GO:0071869) | 2.90545419 |
| 103 | growth hormone receptor signaling pathway (GO:0060396) | 2.90530242 |
| 104 | carnitine shuttle (GO:0006853) | 2.89835364 |
| 105 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.89072242 |
| 106 | regulation of cholesterol storage (GO:0010885) | 2.88791789 |
| 107 | * protein activation cascade (GO:0072376) | 2.88109195 |
| 108 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.87736836 |
| 109 | carnitine transmembrane transport (GO:1902603) | 2.87683529 |
| 110 | regulation of vasculogenesis (GO:2001212) | 2.86605049 |
| 111 | negative regulation of complement activation (GO:0045916) | 2.86037942 |
| 112 | detection of molecule of bacterial origin (GO:0032490) | 2.85957209 |
| 113 | regulation of female receptivity (GO:0045924) | 2.85231655 |
| 114 | fibril organization (GO:0097435) | 2.84995975 |
| 115 | positive regulation of fatty acid oxidation (GO:0046321) | 2.84595546 |
| 116 | potassium ion export (GO:0071435) | 2.84354591 |
| 117 | multicellular organismal metabolic process (GO:0044236) | 2.83052246 |
| 118 | endothelium development (GO:0003158) | 2.82749953 |
| 119 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.81691051 |
| 120 | metanephric tubule development (GO:0072170) | 2.80955684 |
| 121 | metanephric nephron tubule development (GO:0072234) | 2.80955684 |
| 122 | negative regulation of heart growth (GO:0061117) | 2.80445133 |
| 123 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.80445133 |
| 124 | alpha-linolenic acid metabolic process (GO:0036109) | 2.79988592 |
| 125 | collagen metabolic process (GO:0032963) | 2.79845393 |
| 126 | carnitine transport (GO:0015879) | 2.79746612 |
| 127 | amino-acid betaine transport (GO:0015838) | 2.79746612 |
| 128 | endocrine hormone secretion (GO:0060986) | 2.78991764 |
| 129 | cellular response to reactive nitrogen species (GO:1902170) | 2.78018330 |
| 130 | cardiac muscle contraction (GO:0060048) | 2.76432642 |
| 131 | cardiac muscle adaptation (GO:0014887) | 2.74392663 |
| 132 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.74392663 |
| 133 | muscle hypertrophy in response to stress (GO:0003299) | 2.74392663 |
| 134 | positive regulation of male gonad development (GO:2000020) | 2.73702769 |
| 135 | barbed-end actin filament capping (GO:0051016) | 2.72529414 |
| 136 | neutral lipid catabolic process (GO:0046461) | 2.71765356 |
| 137 | acylglycerol catabolic process (GO:0046464) | 2.71765356 |
| 138 | homocysteine metabolic process (GO:0050667) | 2.70699721 |
| 139 | fibroblast migration (GO:0010761) | 2.70600361 |
| 140 | positive regulation of focal adhesion assembly (GO:0051894) | 2.70549961 |
| 141 | positive regulation of cell junction assembly (GO:1901890) | 2.70549961 |
| 142 | response to mineralocorticoid (GO:0051385) | 2.70488156 |
| 143 | cellular response to dexamethasone stimulus (GO:0071549) | 2.68462208 |
| 144 | hypotonic response (GO:0006971) | 2.68376995 |
| 145 | sarcomere organization (GO:0045214) | 2.67239823 |
| 146 | multicellular organismal catabolic process (GO:0044243) | 2.66847756 |
| 147 | collagen catabolic process (GO:0030574) | 2.66394648 |
| 148 | negative regulation of endothelial cell proliferation (GO:0001937) | 2.66024060 |
| 149 | lipid particle organization (GO:0034389) | 2.65019460 |
| 150 | cell migration involved in heart development (GO:0060973) | 2.64708307 |
| 151 | sulfur compound catabolic process (GO:0044273) | 2.64607125 |
| 152 | artery development (GO:0060840) | 2.64044132 |
| 153 | metanephric nephron epithelium development (GO:0072243) | 2.62857734 |
| 154 | cellular response to growth hormone stimulus (GO:0071378) | 2.62800735 |
| 155 | glomerular basement membrane development (GO:0032836) | 2.62323315 |
| 156 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.61318800 |
| 157 | positive regulation of adherens junction organization (GO:1903393) | 2.60467513 |
| 158 | response to folic acid (GO:0051593) | 2.60252403 |
| 159 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.59356462 |
| 160 | positive regulation of macrophage cytokine production (GO:0060907) | 2.58939114 |
| 161 | growth hormone secretion (GO:0030252) | 2.58461572 |
| 162 | metanephric epithelium development (GO:0072207) | 2.57677420 |
| 163 | keratan sulfate biosynthetic process (GO:0018146) | 2.57317039 |
| 164 | response to nitric oxide (GO:0071731) | 2.57209747 |
| 165 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.57046631 |
| 166 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.56514095 |
| 167 | negative regulation of humoral immune response (GO:0002921) | 2.56441179 |
| 168 | toxin metabolic process (GO:0009404) | 2.55319299 |
| 169 | positive regulation of renal sodium excretion (GO:0035815) | 2.54813416 |
| 170 | muscle cell migration (GO:0014812) | 2.54006426 |
| 171 | response to growth hormone (GO:0060416) | 2.53970497 |
| 172 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.53714150 |
| 173 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.53172233 |
| 174 | negative regulation of cell-matrix adhesion (GO:0001953) | 2.53116384 |
| 175 | estrogen metabolic process (GO:0008210) | 2.52341593 |
| 176 | response to dexamethasone (GO:0071548) | 2.51927154 |
| 177 | regulation of Rho protein signal transduction (GO:0035023) | 2.51509103 |
| 178 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.51113046 |
| 179 | fatty acid beta-oxidation (GO:0006635) | 2.49795058 |
| 180 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.48916763 |
| 181 | basement membrane organization (GO:0071711) | 2.48844464 |
| 182 | positive regulation of steroid metabolic process (GO:0045940) | 2.47744226 |
| 183 | cGMP-mediated signaling (GO:0019934) | 2.47526645 |
| 184 | adhesion of symbiont to host (GO:0044406) | 2.47500050 |
| 185 | regulation of plasminogen activation (GO:0010755) | 2.47303569 |
| 186 | atrioventricular valve morphogenesis (GO:0003181) | 2.46929952 |
| 187 | white fat cell differentiation (GO:0050872) | 2.45529634 |
| 188 | glucocorticoid biosynthetic process (GO:0006704) | 13.5220355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.77978570 |
| 2 | GATA1_22025678_ChIP-Seq_K562_Human | 4.91342423 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.84688261 |
| 4 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.47087584 |
| 5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.54221954 |
| 6 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.32215846 |
| 7 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.23514972 |
| 8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.20620773 |
| 9 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.15217843 |
| 10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.13827782 |
| 11 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.11337171 |
| 12 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.07766033 |
| 13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.06974502 |
| 14 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.00963093 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.95709576 |
| 16 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.88812406 |
| 17 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.86561368 |
| 18 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.82420498 |
| 19 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.79328071 |
| 20 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.78387286 |
| 21 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.75189078 |
| 22 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.70218778 |
| 23 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.70218778 |
| 24 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.66776458 |
| 25 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.65219688 |
| 26 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.63772328 |
| 27 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.61317538 |
| 28 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.53400675 |
| 29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.51846241 |
| 30 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.51014585 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.47378006 |
| 32 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.46445889 |
| 33 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.42638911 |
| 34 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.41779679 |
| 35 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.35338739 |
| 36 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.34827067 |
| 37 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.31806532 |
| 38 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.30652928 |
| 39 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.28230077 |
| 40 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.27605716 |
| 41 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.27528709 |
| 42 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.26169514 |
| 43 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24589971 |
| 44 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.22930695 |
| 45 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.19531655 |
| 46 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.19460573 |
| 47 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.19452136 |
| 48 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.19344614 |
| 49 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.17502182 |
| 50 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.13895944 |
| 51 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.11892834 |
| 52 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.08281067 |
| 53 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.06842270 |
| 54 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.06216336 |
| 55 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.05908727 |
| 56 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.05806671 |
| 57 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.05697737 |
| 58 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03664964 |
| 59 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.03452891 |
| 60 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.03168862 |
| 61 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.03115948 |
| 62 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.02566578 |
| 63 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02281418 |
| 64 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.01844352 |
| 65 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99849618 |
| 66 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.99757348 |
| 67 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.99735864 |
| 68 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.98714461 |
| 69 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.98355342 |
| 70 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.97233765 |
| 71 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.97169070 |
| 72 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.97169070 |
| 73 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.96010530 |
| 74 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.95191164 |
| 75 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.95070657 |
| 76 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94959044 |
| 77 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.93373428 |
| 78 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.93372511 |
| 79 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93324283 |
| 80 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93324283 |
| 81 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93078327 |
| 82 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.92265688 |
| 83 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.92176160 |
| 84 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.91831725 |
| 85 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.91528298 |
| 86 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.90612817 |
| 87 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.90253507 |
| 88 | TP53_16413492_ChIP-PET_HCT116_Human | 0.90021339 |
| 89 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.90015788 |
| 90 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89684711 |
| 91 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.89679830 |
| 92 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.89601817 |
| 93 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89428130 |
| 94 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.88793453 |
| 95 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.88705123 |
| 96 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.88325441 |
| 97 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.88160792 |
| 98 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.87096765 |
| 99 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.86959829 |
| 100 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86886266 |
| 101 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85646570 |
| 102 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85005072 |
| 103 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.84618137 |
| 104 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.84073313 |
| 105 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.83642442 |
| 106 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.83625232 |
| 107 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.83322725 |
| 108 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83253352 |
| 109 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.83059173 |
| 110 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.83039222 |
| 111 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.82942271 |
| 112 | KDM2B_26808549_Chip-Seq_K562_Human | 0.81742833 |
| 113 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.81589326 |
| 114 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.81532029 |
| 115 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.81347470 |
| 116 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.81260973 |
| 117 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.80916850 |
| 118 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80853187 |
| 119 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.80779884 |
| 120 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80649432 |
| 121 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.80614514 |
| 122 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80255117 |
| 123 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.79124025 |
| 124 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.78820002 |
| 125 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.78747942 |
| 126 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.77605359 |
| 127 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.77409271 |
| 128 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.77275222 |
| 129 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.76538477 |
| 130 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.76348328 |
| 131 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.75079525 |
| 132 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.75079525 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 6.18108856 |
| 2 | MP0005275_abnormal_skin_tensile | 5.62581527 |
| 3 | MP0005503_abnormal_tendon_morphology | 4.53561085 |
| 4 | MP0001958_emphysema | 3.95856162 |
| 5 | MP0005257_abnormal_intraocular_pressure | 3.36647663 |
| 6 | MP0005670_abnormal_white_adipose | 3.05900428 |
| 7 | MP0000639_abnormal_adrenal_gland | 3.02240193 |
| 8 | MP0002909_abnormal_adrenal_gland | 2.79636026 |
| 9 | MP0004272_abnormal_basement_membrane | 2.67506099 |
| 10 | MP0000751_myopathy | 2.54214903 |
| 11 | MP0010368_abnormal_lymphatic_system | 2.45989720 |
| 12 | MP0002837_dystrophic_cardiac_calcinosis | 2.43231371 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.41171402 |
| 14 | MP0004130_abnormal_muscle_cell | 2.38031489 |
| 15 | MP0005666_abnormal_adipose_tissue | 2.23679685 |
| 16 | MP0003724_increased_susceptibility_to | 2.12680311 |
| 17 | MP0009840_abnormal_foam_cell | 2.07448756 |
| 18 | MP0004185_abnormal_adipocyte_glucose | 1.94136441 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.92291915 |
| 20 | MP0001879_abnormal_lymphatic_vessel | 1.91017042 |
| 21 | MP0002108_abnormal_muscle_morphology | 1.87042990 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 1.84247790 |
| 23 | MP0000013_abnormal_adipose_tissue | 1.78048530 |
| 24 | MP0002295_abnormal_pulmonary_circulatio | 1.77574127 |
| 25 | MP0005375_adipose_tissue_phenotype | 1.76127888 |
| 26 | MP0002127_abnormal_cardiovascular_syste | 1.75105500 |
| 27 | MP0004782_abnormal_surfactant_physiolog | 1.74470753 |
| 28 | MP0003279_aneurysm | 1.67925117 |
| 29 | MP0003566_abnormal_cell_adhesion | 1.61600086 |
| 30 | MP0005410_abnormal_fertilization | 1.60933601 |
| 31 | MP0000343_altered_response_to | 1.59612223 |
| 32 | MP0006054_spinal_hemorrhage | 1.56577880 |
| 33 | MP0003045_fibrosis | 1.52080805 |
| 34 | MP0004085_abnormal_heartbeat | 1.52072403 |
| 35 | MP0002166_altered_tumor_susceptibility | 1.51778944 |
| 36 | MP0000750_abnormal_muscle_regeneration | 1.47240036 |
| 37 | MP0004036_abnormal_muscle_relaxation | 1.47121943 |
| 38 | MP0006138_congestive_heart_failure | 1.44506287 |
| 39 | MP0003137_abnormal_impulse_conducting | 1.42505081 |
| 40 | MP0002060_abnormal_skin_morphology | 1.41012999 |
| 41 | MP0002254_reproductive_system_inflammat | 1.40003350 |
| 42 | MP0005167_abnormal_blood-brain_barrier | 1.37388924 |
| 43 | MP0005388_respiratory_system_phenotype | 1.37212230 |
| 44 | MP0002133_abnormal_respiratory_system | 1.37212230 |
| 45 | MP0004084_abnormal_cardiac_muscle | 1.34553674 |
| 46 | MP0003828_pulmonary_edema | 1.31540297 |
| 47 | MP0000003_abnormal_adipose_tissue | 1.25697354 |
| 48 | MP0009780_abnormal_chondrocyte_physiolo | 1.24198481 |
| 49 | MP0010329_abnormal_lipoprotein_level | 1.22463065 |
| 50 | MP0003300_gastrointestinal_ulcer | 1.19911828 |
| 51 | MP0005508_abnormal_skeleton_morphology | 1.17958176 |
| 52 | MP0002269_muscular_atrophy | 1.17601917 |
| 53 | MP0002971_abnormal_brown_adipose | 1.16098440 |
| 54 | MP0010386_abnormal_urinary_bladder | 1.15136722 |
| 55 | MP0001756_abnormal_urination | 1.14266881 |
| 56 | MP0004087_abnormal_muscle_fiber | 1.13047602 |
| 57 | MP0008004_abnormal_stomach_pH | 1.12635910 |
| 58 | MP0005330_cardiomyopathy | 1.10728594 |
| 59 | MP0003303_peritoneal_inflammation | 1.10657992 |
| 60 | MP0005164_abnormal_response_to | 1.10222532 |
| 61 | MP0005385_cardiovascular_system_phenoty | 1.10133259 |
| 62 | MP0001544_abnormal_cardiovascular_syste | 1.10133259 |
| 63 | MP0003075_altered_response_to | 1.05537126 |
| 64 | MP0002168_other_aberrant_phenotype | 1.03985424 |
| 65 | MP0001661_extended_life_span | 1.03528392 |
| 66 | MP0001765_abnormal_ion_homeostasis | 1.01511198 |
| 67 | MP0003195_calcinosis | 1.00423664 |
| 68 | MP0005620_abnormal_muscle_contractility | 1.00178650 |
| 69 | MP0000249_abnormal_blood_vessel | 0.99742188 |
| 70 | MP0002006_tumorigenesis | 0.99383792 |
| 71 | MP0005023_abnormal_wound_healing | 0.97758450 |
| 72 | MP0003950_abnormal_plasma_membrane | 0.97242587 |
| 73 | MP0009115_abnormal_fat_cell | 0.96044095 |
| 74 | MP0005595_abnormal_vascular_smooth | 0.94985061 |
| 75 | MP0002139_abnormal_hepatobiliary_system | 0.93489015 |
| 76 | MP0000767_abnormal_smooth_muscle | 0.92954887 |
| 77 | MP0005369_muscle_phenotype | 0.91999312 |
| 78 | MP0005334_abnormal_fat_pad | 0.91502481 |
| 79 | MP0002118_abnormal_lipid_homeostasis | 0.91340054 |
| 80 | MP0005332_abnormal_amino_acid | 0.91154719 |
| 81 | MP0008875_abnormal_xenobiotic_pharmacok | 0.91153271 |
| 82 | MP0001984_abnormal_olfaction | 0.90722901 |
| 83 | MP0005165_increased_susceptibility_to | 0.90140637 |
| 84 | MP0000749_muscle_degeneration | 0.89964791 |
| 85 | MP0002896_abnormal_bone_mineralization | 0.88487080 |
| 86 | MP0003646_muscle_fatigue | 0.88129088 |
| 87 | MP0001533_abnormal_skeleton_physiology | 0.86074775 |
| 88 | MP0000230_abnormal_systemic_arterial | 0.84898206 |
| 89 | MP0005636_abnormal_mineral_homeostasis | 0.82802870 |
| 90 | MP0009384_cardiac_valve_regurgitation | 0.82068284 |
| 91 | MP0001177_atelectasis | 0.81985427 |
| 92 | MP0003690_abnormal_glial_cell | 0.80097873 |
| 93 | MP0004019_abnormal_vitamin_homeostasis | 0.79922348 |
| 94 | MP0004215_abnormal_myocardial_fiber | 0.78988760 |
| 95 | MP0005365_abnormal_bile_salt | 0.77965483 |
| 96 | MP0008775_abnormal_heart_ventricle | 0.77801361 |
| 97 | MP0005360_urolithiasis | 0.77586156 |
| 98 | MP0002106_abnormal_muscle_physiology | 0.76289756 |
| 99 | MP0004883_abnormal_blood_vessel | 0.75893226 |
| 100 | MP0010630_abnormal_cardiac_muscle | 0.74829370 |
| 101 | MP0000759_abnormal_skeletal_muscle | 0.74802347 |
| 102 | MP0005390_skeleton_phenotype | 0.74414598 |
| 103 | MP0000266_abnormal_heart_morphology | 0.73910081 |
| 104 | MP0002972_abnormal_cardiac_muscle | 0.72518500 |
| 105 | MP0003329_amyloid_beta_deposits | 0.71928305 |
| 106 | MP0000462_abnormal_digestive_system | 0.71837553 |
| 107 | MP0004484_altered_response_of | 0.71658313 |
| 108 | MP0003252_abnormal_bile_duct | 0.71434168 |
| 109 | MP0002128_abnormal_blood_circulation | 0.71419417 |
| 110 | MP0001542_abnormal_bone_strength | 0.70926776 |
| 111 | MP0000747_muscle_weakness | 0.70590389 |
| 112 | MP0002933_joint_inflammation | 0.70519166 |
| 113 | MP0009643_abnormal_urine_homeostasis | 0.69804654 |
| 114 | MP0003941_abnormal_skin_development | 0.69572042 |
| 115 | MP0003091_abnormal_cell_migration | 0.68503681 |
| 116 | MP0005058_abnormal_lysosome_morphology | 0.66944387 |
| 117 | MP0000534_abnormal_ureter_morphology | 0.65868996 |
| 118 | MP0002796_impaired_skin_barrier | 0.65601938 |
| 119 | MP0008995_early_reproductive_senescence | 0.65325656 |
| 120 | MP0004510_myositis | 0.65090179 |
| 121 | MP0000604_amyloidosis | 0.63970047 |
| 122 | MP0001614_abnormal_blood_vessel | 0.63775635 |
| 123 | MP0004043_abnormal_pH_regulation | 0.63685550 |
| 124 | MP0003567_abnormal_fetal_cardiomyocyte | 0.63157216 |
| 125 | MP0002998_abnormal_bone_remodeling | 0.62966937 |
| 126 | MP0005623_abnormal_meninges_morphology | 0.62730073 |
| 127 | MP0002136_abnormal_kidney_physiology | 0.62728582 |
| 128 | MP0001175_abnormal_lung_morphology | 0.62673818 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Decreased circulating renin level (HP:0003351) | 6.84814635 |
| 2 | Hyperaldosteronism (HP:0000859) | 6.25843130 |
| 3 | Renal salt wasting (HP:0000127) | 6.22456432 |
| 4 | * Abnormality of complement system (HP:0005339) | 5.15327987 |
| 5 | Hypokalemic alkalosis (HP:0001949) | 5.13460134 |
| 6 | Glomerulonephritis (HP:0000099) | 5.12510096 |
| 7 | Increased connective tissue (HP:0009025) | 5.02048857 |
| 8 | Enlarged penis (HP:0000040) | 4.96490645 |
| 9 | Ankle contracture (HP:0006466) | 4.74575649 |
| 10 | Broad metatarsal (HP:0001783) | 4.74259337 |
| 11 | Aortic aneurysm (HP:0004942) | 4.72838290 |
| 12 | Abnormality of renin-angiotensin system (HP:0000847) | 4.54432870 |
| 13 | Protrusio acetabuli (HP:0003179) | 4.53170017 |
| 14 | Muscle fiber splitting (HP:0003555) | 4.40806541 |
| 15 | Aortic dissection (HP:0002647) | 4.32517884 |
| 16 | Type 1 muscle fiber predominance (HP:0003803) | 4.14806238 |
| 17 | Abnormality of the nasal mucosa (HP:0000433) | 4.00777217 |
| 18 | Cerebral aneurysm (HP:0004944) | 3.83169299 |
| 19 | Facial diplegia (HP:0001349) | 3.78902596 |
| 20 | Atrial fibrillation (HP:0005110) | 3.75688675 |
| 21 | Adrenal overactivity (HP:0002717) | 3.72974083 |
| 22 | Papilledema (HP:0001085) | 3.68897578 |
| 23 | Hematochezia (HP:0002573) | 3.68660328 |
| 24 | Polycythemia (HP:0001901) | 3.66582851 |
| 25 | Nephritis (HP:0000123) | 3.65118822 |
| 26 | Syncope (HP:0001279) | 3.63863285 |
| 27 | Hypokalemia (HP:0002900) | 3.57148903 |
| 28 | Rectal prolapse (HP:0002035) | 3.46253746 |
| 29 | Facial shape deformation (HP:0011334) | 3.45210872 |
| 30 | Potter facies (HP:0002009) | 3.45210872 |
| 31 | Spinal rigidity (HP:0003306) | 3.35329441 |
| 32 | Primary atrial arrhythmia (HP:0001692) | 3.33694239 |
| 33 | Flat cornea (HP:0007720) | 3.29032824 |
| 34 | Premature rupture of membranes (HP:0001788) | 3.28369430 |
| 35 | Hypoplasia of the uterus (HP:0000013) | 3.27182362 |
| 36 | Increased variability in muscle fiber diameter (HP:0003557) | 3.26248012 |
| 37 | Follicular hyperkeratosis (HP:0007502) | 3.22749417 |
| 38 | Supraventricular tachycardia (HP:0004755) | 3.15590810 |
| 39 | Ventricular fibrillation (HP:0001663) | 3.14890534 |
| 40 | Supraventricular arrhythmia (HP:0005115) | 3.13218833 |
| 41 | Prolonged QT interval (HP:0001657) | 3.10580675 |
| 42 | Amyloidosis (HP:0011034) | 3.06451004 |
| 43 | Chronic bronchitis (HP:0004469) | 3.04312064 |
| 44 | Lymphangioma (HP:0100764) | 3.02760676 |
| 45 | Hyporeflexia of lower limbs (HP:0002600) | 3.00573696 |
| 46 | Acanthosis nigricans (HP:0000956) | 3.00084343 |
| 47 | Interstitial pulmonary disease (HP:0006530) | 2.98349182 |
| 48 | Pulmonary artery stenosis (HP:0004415) | 2.96259320 |
| 49 | Wrist flexion contracture (HP:0001239) | 2.92866416 |
| 50 | Spontaneous hematomas (HP:0007420) | 2.90845478 |
| 51 | Soft skin (HP:0000977) | 2.89296638 |
| 52 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.87193335 |
| 53 | Oligomenorrhea (HP:0000876) | 2.85944927 |
| 54 | Striae distensae (HP:0001065) | 2.85019103 |
| 55 | Growth hormone excess (HP:0000845) | 2.84347379 |
| 56 | Atrioventricular block (HP:0001678) | 2.82468586 |
| 57 | Round ear (HP:0100830) | 2.81285735 |
| 58 | Increased circulating renin level (HP:0000848) | 2.79690747 |
| 59 | Alkalosis (HP:0001948) | 2.79046017 |
| 60 | Mitral valve prolapse (HP:0001634) | 2.78439149 |
| 61 | Aneurysm (HP:0002617) | 2.75566006 |
| 62 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.74023895 |
| 63 | Osteolytic defects of the hand bones (HP:0009699) | 2.74023895 |
| 64 | Right ventricular cardiomyopathy (HP:0011663) | 2.72994936 |
| 65 | Systemic lupus erythematosus (HP:0002725) | 2.68052230 |
| 66 | Abnormality of potassium homeostasis (HP:0011042) | 2.66584106 |
| 67 | Bundle branch block (HP:0011710) | 2.65779451 |
| 68 | Slender build (HP:0001533) | 2.62773182 |
| 69 | Metabolic alkalosis (HP:0200114) | 2.59238743 |
| 70 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.51354708 |
| 71 | Shallow orbits (HP:0000586) | 2.49529204 |
| 72 | Persistence of primary teeth (HP:0006335) | 2.47042598 |
| 73 | Abnormal atrioventricular conduction (HP:0005150) | 2.44272285 |
| 74 | Camptodactyly of toe (HP:0001836) | 2.44161669 |
| 75 | Heart block (HP:0012722) | 2.43924279 |
| 76 | Tubulointerstitial fibrosis (HP:0005576) | 2.43517541 |
| 77 | * Complement deficiency (HP:0004431) | 2.39612395 |
| 78 | Hyperkalemia (HP:0002153) | 2.37682538 |
| 79 | Mesangial abnormality (HP:0001966) | 2.37524498 |
| 80 | Sudden death (HP:0001699) | 2.37335041 |
| 81 | Testicular neoplasm (HP:0010788) | 2.36857820 |
| 82 | Broad ribs (HP:0000885) | 2.36714377 |
| 83 | Ventricular arrhythmia (HP:0004308) | 2.36378147 |
| 84 | Bladder diverticulum (HP:0000015) | 2.35431117 |
| 85 | Long toe (HP:0010511) | 2.34413611 |
| 86 | Patent foramen ovale (HP:0001655) | 2.34217558 |
| 87 | Metaphyseal dysplasia (HP:0100255) | 2.32443507 |
| 88 | Bronchomalacia (HP:0002780) | 2.31336297 |
| 89 | Abnormality of the fingertips (HP:0001211) | 2.30771199 |
| 90 | Dilatation of the ascending aorta (HP:0005111) | 2.29592005 |
| 91 | Congenital sensorineural hearing impairment (HP:0008527) | 2.28172522 |
| 92 | Esophageal varix (HP:0002040) | 2.26534230 |
| 93 | Neonatal onset (HP:0003623) | 2.26432932 |
| 94 | Nasal polyposis (HP:0100582) | 2.24340862 |
| 95 | Hyperactive renin-angiotensin system (HP:0000841) | 2.24195390 |
| 96 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.23954554 |
| 97 | Difficulty running (HP:0009046) | 2.19589518 |
| 98 | Increased density of long bones (HP:0006392) | 2.19213669 |
| 99 | Vascular tortuosity (HP:0004948) | 2.18164520 |
| 100 | Accelerated skeletal maturation (HP:0005616) | 2.16667670 |
| 101 | Cervical subluxation (HP:0003308) | 2.15730007 |
| 102 | Abnormal EKG (HP:0003115) | 2.13666388 |
| 103 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.12208540 |
| 104 | Hemorrhage of the eye (HP:0011885) | 2.11550253 |
| 105 | Joint hemorrhage (HP:0005261) | 2.11409431 |
| 106 | Visceral angiomatosis (HP:0100761) | 2.11188448 |
| 107 | Exercise-induced myalgia (HP:0003738) | 2.10179443 |
| 108 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.08493656 |
| 109 | Aortic regurgitation (HP:0001659) | 2.07278103 |
| 110 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.07229754 |
| 111 | Bulbar palsy (HP:0001283) | 2.05570458 |
| 112 | Skin nodule (HP:0200036) | 2.02944615 |
| 113 | Venous abnormality (HP:0002624) | 2.02120632 |
| 114 | Deep venous thrombosis (HP:0002625) | 2.01196890 |
| 115 | Proximal amyotrophy (HP:0007126) | 1.99908666 |
| 116 | Cerebral hemorrhage (HP:0001342) | 1.99409760 |
| 117 | Atrophic scars (HP:0001075) | 1.98378568 |
| 118 | Hypoplasia of the iris (HP:0007676) | 1.97869854 |
| 119 | Limited hip movement (HP:0008800) | 1.97813270 |
| 120 | Lipoatrophy (HP:0100578) | 1.97137539 |
| 121 | Xanthomatosis (HP:0000991) | 1.96736132 |
| 122 | Hypertriglyceridemia (HP:0002155) | 1.96663338 |
| 123 | Hyperextensible skin (HP:0000974) | 1.94646260 |
| 124 | Abnormality of chloride homeostasis (HP:0011422) | 1.93689764 |
| 125 | Venous insufficiency (HP:0005293) | 1.93670817 |
| 126 | Overgrowth (HP:0001548) | 1.93247238 |
| 127 | Myoglobinuria (HP:0002913) | 1.92935469 |
| 128 | Gastrointestinal dysmotility (HP:0002579) | 1.90472785 |
| 129 | Hemangiomatosis (HP:0007461) | 1.89345555 |
| 130 | Abnormal urine output (HP:0012590) | 1.88545859 |
| 131 | Abnormality of the axillary hair (HP:0100134) | 1.88068703 |
| 132 | Abnormality of secondary sexual hair (HP:0009888) | 1.88068703 |
| 133 | Stroke (HP:0001297) | 1.87348832 |
| 134 | Male pseudohermaphroditism (HP:0000037) | 1.86379687 |
| 135 | Disproportionate tall stature (HP:0001519) | 1.86264789 |
| 136 | Wormian bones (HP:0002645) | 1.86094579 |
| 137 | Subcapsular cataract (HP:0000523) | 1.86025545 |
| 138 | Ventricular tachycardia (HP:0004756) | 1.85276427 |
| 139 | Joint laxity (HP:0001388) | 1.84202946 |
| 140 | Conjunctival telangiectasia (HP:0000524) | 1.81039761 |
| 141 | Bronchitis (HP:0012387) | 1.80838932 |
| 142 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.80764590 |
| 143 | Polyuria (HP:0000103) | 1.79751395 |
| 144 | Hip contracture (HP:0003273) | 1.78062015 |
| 145 | Mitral stenosis (HP:0001718) | 1.76913170 |
| 146 | Gonadal dysgenesis (HP:0000133) | 1.75958689 |
| 147 | Flexion contracture of toe (HP:0005830) | 1.74455577 |
| 148 | Joint contractures involving the joints of the feet (HP:0100492) | 1.74455577 |
| 149 | Joint stiffness (HP:0001387) | 1.73827123 |
| 150 | Hypercortisolism (HP:0001578) | 1.73661949 |
| 151 | Cardiovascular calcification (HP:0011915) | 1.73173006 |
| 152 | Clitoromegaly (HP:0000057) | 1.72544966 |
| 153 | Abnormal cartilage morphology (HP:0002763) | 1.72261164 |
| 154 | Aplasia of the musculature (HP:0100854) | 1.71748532 |
| 155 | Dilated cardiomyopathy (HP:0001644) | 1.71593234 |
| 156 | Asymmetric septal hypertrophy (HP:0001670) | 1.70967092 |
| 157 | Abnormality of renal excretion (HP:0011036) | 1.70548928 |
| 158 | Ulnar bowing (HP:0003031) | 1.70411614 |
| 159 | Arterial tortuosity (HP:0005116) | 1.70236399 |
| 160 | Abnormality of the calf musculature (HP:0001430) | 1.69634314 |
| 161 | Short hallux (HP:0010109) | 1.69416147 |
| 162 | Abnormal sex determination (HP:0012244) | 1.67904687 |
| 163 | Sex reversal (HP:0012245) | 1.67904687 |
| 164 | Pulmonary hypertension (HP:0002092) | 1.66637340 |
| 165 | Distal lower limb muscle weakness (HP:0009053) | 1.64619968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 4.30057035 |
| 2 | MYLK | 4.15475690 |
| 3 | TRIB3 | 3.43951687 |
| 4 | TTN | 3.17665114 |
| 5 | TGFBR2 | 3.06636713 |
| 6 | PDK3 | 2.90174599 |
| 7 | PDK4 | 2.90174599 |
| 8 | RIPK1 | 2.81304850 |
| 9 | ERN1 | 2.70861133 |
| 10 | WNK3 | 2.56115511 |
| 11 | CAMK1D | 2.42869663 |
| 12 | LMTK2 | 2.34958134 |
| 13 | SIK1 | 2.12274057 |
| 14 | DDR2 | 2.09473508 |
| 15 | PDGFRA | 2.07640263 |
| 16 | PDK2 | 2.03370055 |
| 17 | DMPK | 1.99767746 |
| 18 | CAMK1G | 1.97273690 |
| 19 | NLK | 1.83300433 |
| 20 | EPHB2 | 1.68433846 |
| 21 | PRKD3 | 1.65177214 |
| 22 | FGFR2 | 1.63624861 |
| 23 | FGFR4 | 1.62689515 |
| 24 | EPHB1 | 1.62380165 |
| 25 | LATS1 | 1.60927943 |
| 26 | MELK | 1.60640852 |
| 27 | FER | 1.53273880 |
| 28 | CSK | 1.48961014 |
| 29 | OXSR1 | 1.48056414 |
| 30 | MST1R | 1.47420180 |
| 31 | MAP3K5 | 1.46434607 |
| 32 | SGK2 | 1.46052766 |
| 33 | FRK | 1.38216147 |
| 34 | STK38L | 1.32389838 |
| 35 | PTK2B | 1.30632972 |
| 36 | PAK2 | 1.27242410 |
| 37 | TRPM7 | 1.22574293 |
| 38 | PHKG1 | 1.18738795 |
| 39 | PHKG2 | 1.18738795 |
| 40 | BCKDK | 1.18152173 |
| 41 | MAP3K3 | 1.17913180 |
| 42 | SGK494 | 1.17125095 |
| 43 | SGK223 | 1.17125095 |
| 44 | TESK1 | 1.16973625 |
| 45 | FGFR3 | 1.16540533 |
| 46 | EPHA3 | 1.12886482 |
| 47 | SGK3 | 1.12854231 |
| 48 | LRRK2 | 1.09075612 |
| 49 | PDGFRB | 1.04329938 |
| 50 | PRKCH | 0.99733087 |
| 51 | PIK3CG | 0.97097302 |
| 52 | MAP3K6 | 0.95879797 |
| 53 | MAP2K3 | 0.92500910 |
| 54 | GSK3A | 0.90660284 |
| 55 | MET | 0.90447843 |
| 56 | INSRR | 0.88213936 |
| 57 | AKT3 | 0.87940470 |
| 58 | PTK6 | 0.86753119 |
| 59 | DAPK2 | 0.85803460 |
| 60 | JAK1 | 0.85142361 |
| 61 | MAPK7 | 0.83315741 |
| 62 | ICK | 0.79215531 |
| 63 | OBSCN | 0.76611486 |
| 64 | NTRK1 | 0.76089563 |
| 65 | ILK | 0.75706006 |
| 66 | PRPF4B | 0.74965191 |
| 67 | MAPKAPK3 | 0.74834843 |
| 68 | PRKD1 | 0.74452505 |
| 69 | TGFBR1 | 0.73481865 |
| 70 | JAK2 | 0.73062887 |
| 71 | PKN2 | 0.72862617 |
| 72 | MAPK15 | 0.72584571 |
| 73 | PIK3CA | 0.71358494 |
| 74 | MAP3K2 | 0.70937667 |
| 75 | PRKAA2 | 0.69308579 |
| 76 | KIT | 0.67503602 |
| 77 | CAMK4 | 0.66677420 |
| 78 | PAK4 | 0.65331463 |
| 79 | PDPK1 | 0.63182816 |
| 80 | IRAK1 | 0.62496152 |
| 81 | RPS6KA2 | 0.61317394 |
| 82 | RET | 0.60445595 |
| 83 | TAOK3 | 0.58731038 |
| 84 | MAP3K7 | 0.56924902 |
| 85 | PRKCE | 0.56252892 |
| 86 | ROCK2 | 0.55336788 |
| 87 | ROCK1 | 0.55040486 |
| 88 | KDR | 0.52255772 |
| 89 | MUSK | 0.50737607 |
| 90 | MAP2K1 | 0.50350310 |
| 91 | STK39 | 0.50348448 |
| 92 | WNK4 | 0.50326566 |
| 93 | RPS6KC1 | 0.48516012 |
| 94 | RPS6KL1 | 0.48516012 |
| 95 | GRK1 | 0.47706801 |
| 96 | MTOR | 0.47243488 |
| 97 | MAPK3 | 0.46670417 |
| 98 | NTRK3 | 0.46519356 |
| 99 | STK38 | 0.45664783 |
| 100 | STK3 | 0.45353395 |
| 101 | PTK2 | 0.45343511 |
| 102 | AKT2 | 0.44808196 |
| 103 | PRKD2 | 0.44679874 |
| 104 | SGK1 | 0.44626631 |
| 105 | CAMK2D | 0.43709559 |
| 106 | WNK1 | 0.43132474 |
| 107 | PRKACA | 0.42655487 |
| 108 | DAPK3 | 0.41977520 |
| 109 | HIPK2 | 0.41926866 |
| 110 | EEF2K | 0.41858196 |
| 111 | LATS2 | 0.40731458 |
| 112 | TYK2 | 0.39961700 |
| 113 | PDK1 | 0.39473858 |
| 114 | MARK2 | 0.39423436 |
| 115 | NEK9 | 0.39313938 |
| 116 | RPS6KA6 | 0.39290254 |
| 117 | SRC | 0.38204999 |
| 118 | CDC42BPA | 0.36618288 |
| 119 | STK10 | 0.36238491 |
| 120 | PRKAA1 | 0.35735129 |
| 121 | MAPK12 | 0.34317105 |
| 122 | EGFR | 0.33931779 |
| 123 | PINK1 | 0.33909625 |
| 124 | MAPK4 | 0.32086291 |
| 125 | PRKG1 | 0.31829493 |
| 126 | BMX | 0.31686342 |
| 127 | CDK6 | 0.31109137 |
| 128 | PAK3 | 0.30789952 |
| 129 | PRKACG | 0.30557246 |
| 130 | TYRO3 | 0.30426885 |
| 131 | ZAP70 | 0.28726847 |
| 132 | INSR | 0.28206167 |
| 133 | IGF1R | 0.27338953 |
| 134 | CAMK1 | 0.25239030 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 3.53969608 |
| 2 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.39220825 |
| 3 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.72821528 |
| 4 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.68710381 |
| 5 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.56992577 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.45386657 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.26340002 |
| 8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.16004675 |
| 9 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.10650635 |
| 10 | Focal adhesion_Homo sapiens_hsa04510 | 2.07625561 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.96376675 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.82524146 |
| 13 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.81633864 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.77247739 |
| 15 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.68160151 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 1.67255898 |
| 17 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.56477907 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.46522990 |
| 19 | Renin secretion_Homo sapiens_hsa04924 | 1.45467584 |
| 20 | ABC transporters_Homo sapiens_hsa02010 | 1.42941169 |
| 21 | Retinol metabolism_Homo sapiens_hsa00830 | 1.40434925 |
| 22 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.38734522 |
| 23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.38450058 |
| 24 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.37145862 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.35568295 |
| 26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.33698584 |
| 27 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.33286817 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.32378025 |
| 29 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.30867898 |
| 30 | Insulin resistance_Homo sapiens_hsa04931 | 1.28762241 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.23441735 |
| 32 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.20084871 |
| 33 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.19576933 |
| 34 | Amoebiasis_Homo sapiens_hsa05146 | 1.16892072 |
| 35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.13076273 |
| 36 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.09504955 |
| 37 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.05304824 |
| 38 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.96742665 |
| 39 | * Prion diseases_Homo sapiens_hsa05020 | 0.95935509 |
| 40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.94277089 |
| 41 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.89686598 |
| 42 | Carbon metabolism_Homo sapiens_hsa01200 | 0.87941096 |
| 43 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.86548860 |
| 44 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.86240091 |
| 45 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.85707513 |
| 46 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.83144764 |
| 47 | Circadian rhythm_Homo sapiens_hsa04710 | 0.81236317 |
| 48 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.81144693 |
| 49 | Adherens junction_Homo sapiens_hsa04520 | 0.80923133 |
| 50 | Bile secretion_Homo sapiens_hsa04976 | 0.80497826 |
| 51 | Platelet activation_Homo sapiens_hsa04611 | 0.80429739 |
| 52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.78616226 |
| 53 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.77856302 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77820711 |
| 55 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.76462117 |
| 56 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.76316108 |
| 57 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.75482034 |
| 58 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.74900815 |
| 59 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.74260391 |
| 60 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.73421630 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73417602 |
| 62 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72446327 |
| 63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.72059891 |
| 64 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.70731731 |
| 65 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.69957918 |
| 66 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.68279088 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67785348 |
| 68 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.67108264 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.65965499 |
| 70 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.65687031 |
| 71 | Viral myocarditis_Homo sapiens_hsa05416 | 0.64632744 |
| 72 | Tight junction_Homo sapiens_hsa04530 | 0.64581800 |
| 73 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.63995741 |
| 74 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.63934149 |
| 75 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.62719295 |
| 76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61325920 |
| 77 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.61248662 |
| 78 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.60780534 |
| 79 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.60689099 |
| 80 | Peroxisome_Homo sapiens_hsa04146 | 0.60215925 |
| 81 | Lysosome_Homo sapiens_hsa04142 | 0.59921621 |
| 82 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59823832 |
| 83 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.58451901 |
| 84 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.57851146 |
| 85 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57577233 |
| 86 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.55746685 |
| 87 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.54230163 |
| 88 | Salivary secretion_Homo sapiens_hsa04970 | 0.54153952 |
| 89 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.52911971 |
| 90 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.52803465 |
| 91 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.52353276 |
| 92 | Gap junction_Homo sapiens_hsa04540 | 0.52258675 |
| 93 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52155214 |
| 94 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.51207549 |
| 95 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.50673447 |
| 96 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.49666775 |
| 97 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.49535316 |
| 98 | Phagosome_Homo sapiens_hsa04145 | 0.49527609 |
| 99 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.49137962 |
| 100 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.47481916 |
| 101 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.46423208 |
| 102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.46285867 |
| 103 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44060149 |
| 104 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.43271911 |
| 105 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.43191549 |
| 106 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41585798 |
| 107 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.40997911 |
| 108 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.40725349 |
| 109 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.40561732 |
| 110 | Lysine degradation_Homo sapiens_hsa00310 | 0.40550716 |
| 111 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.40260671 |
| 112 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.40044834 |
| 113 | Other glycan degradation_Homo sapiens_hsa00511 | 0.39731562 |
| 114 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.39514908 |
| 115 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.38809383 |
| 116 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.38539148 |
| 117 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37607474 |
| 118 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.32705382 |
| 119 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32602417 |
| 120 | Endocytosis_Homo sapiens_hsa04144 | 0.31928504 |
| 121 | Bladder cancer_Homo sapiens_hsa05219 | 0.31311644 |
| 122 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.31264828 |
| 123 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.31148565 |
| 124 | Mineral absorption_Homo sapiens_hsa04978 | 0.29846164 |
| 125 | Circadian entrainment_Homo sapiens_hsa04713 | 0.28364234 |
| 126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27932802 |

